Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Adjuvant Chemotherapy with Cisplatin plus Paclitaxel in Non-Small Cell Lung Cancer Patient.
10.4046/trd.2006.61.6.591
- Author:
Yong Soo BAEK
1
;
Jeong Seon RYU
;
Seong Bin HONG
;
Sung Soo YOO
;
Hyung Kwon YU
;
Dong Wook SON
;
Lucia KIM
;
Hye Sun KANG
;
Beom Joon KIM
;
Kyung Hee LEE
;
Jae Hwa CHO
;
Young Han YOON
;
Seung Min KWAK
;
Hong Lyeol LEE
;
Kwang Ho KIM
Author Information
1. Department of Internal Medicine, College of Medicine, Inha University, Incheon, South Korea. jsryu@inha.ac.kr
- Publication Type:Case Report
- Keywords:
Syndrome of inappropriate secretion of antidiuretic hormone;
Chemotherapy;
Non-small cell lung cancer;
Seizure
- MeSH:
Adenocarcinoma;
Brain;
Carcinoma, Non-Small-Cell Lung*;
Chemotherapy, Adjuvant*;
Cisplatin*;
Drug Therapy;
Drug Therapy, Combination;
Emergency Service, Hospital;
Female;
Humans;
Inappropriate ADH Syndrome;
Magnetic Resonance Imaging;
Middle Aged;
Neoplasm Metastasis;
Osmolar Concentration;
Paclitaxel*;
Plasma;
Seizures;
Sodium
- From:Tuberculosis and Respiratory Diseases
2006;61(6):591-594
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
We report a case of pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following adjuvant chemotherapy. A 51-year-old woman with stage IIIA adenocarcinoma received left lower lobe lobectomy in July, 2006. And then combination chemotherapy with paclitaxel and cisplatin was given to the patient. In five days after completion of second cycle of the chemotherapy, she visited emergency room because of general weakness and seizure. Her brain MRI was shown to be no evidence of brain metastasis. Serum sodium, urine and plasma osmolarities were 117mEq/L, 589 and 244mOsm/kg, respectively. She was improved with fluid restriction. Although occurrence of SIADH following chemotherapy is rare, physician should give an attention the potential for development of SIADH in the course of chemotherapyin non-small cell lung cancer patient.
